| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $237.5M | — | +20.5% |
| R&D Expense | $10.6M | — | +0.3% |
| SG&A Expense | $73.7M | — | -3.8% |
| Operating Income | $38.9M | — | +48.5% |
| Interest Expense | $7.6M | — | -6.8% |
| Pre-tax Income | $40.2M | — | +101.2% |
| Income Tax | $10.7M | — | +149.2% |
| Net Income | $29.5M | — | +88.1% |
| EPS (Basic) | $1.31 | — | +87.1% |
| EPS (Diluted) | $1.28 | — | +85.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $311.2M | +9.0% | +107.7% |
| Accounts Receivable | $255.4M | -9.1% | +15.9% |
| Inventory | $143.5M | +0.3% | +4.4% |
| Current Assets | $747.1M | -0.8% | +39.3% |
| Total Assets | $1.42B | -1.3% | +10.0% |
| Current Liabilities | $239.5M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $58.4M | — | +66.8% |
| Capital Expenditures | $6.1M | — | +145.5% |
| Investing Cash Flow | -$11.3M | — | +42.9% |
| Financing Cash Flow | -$21.6M | — | -118.2% |
| Free Cash Flow | $52.3M | — | +60.8% |
| +18.7% |
| Long-term Debt | $286.0M | -2.0% | -6.3% |
| Total Liabilities | $859.7M | -4.4% | +1.3% |
| Stockholders' Equity | $562.3M | +4.0% | +34.3% |